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Abstract
Recent studies have shown that basic cellular behavior varies significantly between two- and three-
dimensional culture systems. To identify the origins of these fundamental differences the design of 
reliable and precisely controlled environments is essential. While 2D cell culture is a well-
established technique, the fabrication of defined three-dimensional culture models is still 
challenging. We present a new method for the microfluidic generation of a micron-sized three-
dimensional cell culture system. We use a triggered ionic crosslink formation to generate highly 
monodisperse and structurally homogeneous alginate microbeads. Aqueous droplets containing a 
mixture of alginate and a water-soluble calcium-EDTA complex are formed by droplet-based 
microfluidics. In their complexed form, the calcium ions are homogenously distributed inside the 
droplet but not accessible for the crosslinking process. Acid addition is used to trigger the 
degradation of the complex, releasing calcium ions on demand that can physically crosslink the 
alginate chains. A homogeneous hydrogel network is thus generated which can be transferred into 
an aqueous environment without losing its structural integrity. Single cells can be encapsulated 
into these controlled microenvironments which provide structural support while allowing for 
continuous nutrient supply. We encapsulate individual mesenchymal stem cells (MSCs) into the 
microbeads which show the aspired cell growth and proliferation.
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Micron-sized alginate particles are used for the encapsulation of living cells in 
pharmaceutical research, tissue engineering and regenerative medicine.1–5 Such microgels 
act as micron-sized 3D culturing units allowing individual cells to be independently 
monitored or manipulated for example to study the role confinement on cell fate or to deliver 
cells for the repair of damaged tissue.6,7 The ideal microgel particles for these applications 
should be composed of a homogenous network structure to allow the stable entrapment of 
the encapsulated cell in a controlled microenvironment with precise internal structure. 
Additionally, particle sizes should be small (< 200 µm) to allow effective delivery of oxygen 
and nutrients to the encapsulated cell which is essential for cell viability and health.8–10 In 
tissue engineering, cell-containing microgels are also used as building blocks which are 
assembled into larger architectures mimicking the structure of tissues and organs.7,11 Since 
cell-cell distances and structural arrangement have significant influence on cellular 
properties and function, a precise control over size and size distribution is of key 
importance.12
Alginate microgel particles can be produced by means of droplet-based microfluidics which 
combines high-throughput production with precise control over size, shape and morphology 
of the generated droplets.3,9,13–15 Typically, an aqueous alginate solution is emulsified in an 
oil phase and crosslinked ionically with bivalent ions such as Ca2+. The ionic crosslinking 
process occurs immediately upon contact of alginate chains and calcium ions. The fast 
reaction typically results in uncontrolled gelation within the microfluidic device which can 
cause clogging and non-uniform drop formation.8,16 To overcome these problems, the drop 
formation and the gelation reaction must be separated. Thus, calcium ions need to be 
delivered to the alginate solution without inducing unintended gelation prior to drop 
formation.
One route to achieve this goal is the use of calcium carbonate (CaCO3) nanoparticles.2,13,17 
The water-insoluble particles are dispersed in the alginate solution and can be dissolved 
under acidic conditions after drop formation. Premature gelation is avoided and 
monodisperse particles result. However, the dissolution of solid calcium salt particles causes 
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a heterogeneous distribution of calcium ions inside the droplets and diminishes the 
homogeneity of the resulting particles. Additionally, clogging of small microfluidic channels 
in the presence of particle aggregates limits the range of accessible microgel dimensions.13 
Other techniques involves the initiation of the crosslinking process by the delivery of 
calcium chlorides or acetate particles through the oil phase which are subsequently dissolved 
in the emulsion droplet.17,28 Nevertheless, this method can suffer from the same problems, 
namely inhomogeneous calcium distribution or clogging issues. Alternatively, the generation 
of alginate microgels via coalescence of separate droplets containing alginate and calcium 
chloride has been tried.18 However, mixing inside the coalesced droplets still results in 
heterogeneous particles since crosslinking takes place before a homogenous distribution of 
calcium ions can be achieved. Additionally, coalescence generally results in a volume 
increase of the final, crosslinked alginate microgels.17
If we were able to control the crosslinking process, homogenous microgel particles with 
reliable and precisely tunable particle properties would become accessible. This would allow 
us to study the influence of the physical properties of the microgel matrix on the behavior of 
the encapsulated cell in three dimensions which is of great importance for applications in 
tissue engineering, stem cell research and the treatment of diseases.19–21 However, the 
limited homogeneity of available alginate microgels particles restricts these applications.
In this communication, we present a method for the fabrication of monodisperse alginate 
microgels with structural homogeneity via droplet-based microfluidics. We deliver calcium 
ions in form of a water-soluble calcium-ethylenediaminetetraacetic acid (calcium-EDTA) 
complex. By chelating the calcium ions with EDTA, the ions remain in solution but are 
inaccessible to the alginate chains. Using droplet-based microfluidics, we emulsify a 
perfectly homogenous mixture of alginate and the chelated calcium ions without inducing 
unintended gelation. By addition of acetic acid to the continuous phase, we trigger the 
dissociation of the complex and release calcium ions after drop formation. The free ions 
react with the alginate chains in a highly controlled fashion forming alginate microgels with 
excellent structural homogeneity. By separating drop formation and crosslinking in this 
purely aqueous system, we eliminate clogging issues and generate alginate microgel 
particles with particle size down to ten micrometers and narrow particle size distributions. 
We demonstrate that the gelation process is suitable for the encapsulation of living cells by 
encapsulating individual mesenchymal stem cells (MSCs). Our mild polymerization 
technique allows us to encapsulate the cells with high viability. We culture and monitor the 
encapsulated cells inside the microgels over the course of two weeks within which we 
observe stable encapsulation, healthy cells, growth and proliferation.
We prepare monodisperse, structurally homogeneous alginate microgels in the size range of 
10 – 50 µm by acidic dissociation of a water-soluble calcium-EDTA complex within an 
alginate containing emulsion droplet. We form the calcium-EDTA complex by mixing a 
solution of calcium chloride (100 mM) with a solution of disodium-EDTA (100 mM) in 
equal ratios, schematically illustrated in Figure 1 We adjust the pH value of the solution 
using sodium hydroxide until we reach a pH of 7. Under neutral conditions the complex is 
highly stable. The chelation of calcium ions with EDTA keeps the ions in solution but 
impedes their reaction with alginate chains. We thus prepare a homogenous mixture of the 
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aqueous calcium-EDTA complex solution (50 mM) and an aqueous alginate solution (2 wt% 
MVG, Novamatrix). We use a FITC-labeled alginate, prepared using carbodiimide 
chemistry, which enables visualization of the internal structure of the microgel after 
polymerization using fluorescence microscopy.7 The premixed alginate-calcium-EDTA 
complex solution is emulsified into monodisperse droplets using a microfluidic flow-
focusing device as shown in Figure 1b,c. Fluorinated carbon oil (HFE7500, 3M) containing 
1 wt% of a biocompatible surfactant is used as the continuous phase.22 After drop formation, 
gelation is induced by addition of acetic acid (0.05 vol%) to the oil phase. The acid diffuses 
into the droplets and causes a decrease in pH, leading to the dissociation of the Ca-EDTA 
complex and the release of calcium ions. The liberated calcium ions then react with the 
alginate chains creating uniformly crosslinked microgel particles, illustrated in Figure 1d. 
After gelation, the microgels are transferred into aqueous medium. The water-soluble nature 
of the complex eliminates clogging issues arising in case of solid crosslinking precursors 
and allows the homogenous distribution of calcium ions inside the aqueous droplet prior to 
gelation.2,13,17 We avoid premature gelation by the time-controlled dissociation of the 
complex which furthermore allows the separation of drop formation and crosslinking 
process resulting in a highly controlled and consequently, reliable and reproducible drop and 
subsequent particle generation. Bright-field images of the microgels, taken after transfer to 
an aqueous medium reveal the high monodispersity of the particles as shown in Figure 2a. 
Fluorescence microscopy images illustrate the internal morphology of the microgel particles. 
The fluorescence intensity and consequently the concentration of alginate are homogenous 
throughout the particle confirming the expected structural homogeneity, visible in Figure 2b. 
A comparison between different preparation methods of microfluidically generated alginate 
microgels nicely demonstrates the superior homogeneity of the presented particles as shown 
in Figure S1.
Alginate microgels can also be prepared by using higher concentration of the calcium-EDTA 
complex (data not shown). However, the limited solubility of EDTA in water which is 
around 0.26 M at 20°C can cause the formation of insoluble precipitates which impedes the 
aspired structural homogeneity. The same problem occurs for calcium-EDTA concentrations 
higher than 100 mM when mixed with 2 % alginate. The concentration of calcium-EDTA 
can also be lower than the ones applied here. However, the critical calcium concentration 
necessary to ensure complete gelation of alginate has been reported to be in the order of 25 
mM.27 The relation between calcium-EDTA concentration and drop formation efficiency is 
illustrated in Figure S2. A 2% alginate concentration is the highest concentration that can be 
used under the presented conditions. The high viscosity of alginate solutions with 
concentrations higher than 2 wt% result in debonding of the microfluidic device due to the 
high pressures generated inside the microchannels, especially in case of small dropmakers.
The size of the alginate microgels can be adjusted by changing the size of the microfluidic 
device and the applied flow rates. We use three flow-focusing devices with different square 
cross-sectional dimensions. We keep the flow rate of the alginate-calcium-EDTA solution 
constant (50 µL/h) while varying the flow rate of the continuous phase from 100 µL/h to 500 
µL/h, thereby decreasing the drop size for a given dropmaker. We prepare particles as small 
as 10 µm using a microfluidic device with a 10-µm-square cross-sectional channel. Larger 
gel sizes are made with larger microfluidic channels as shown for 25 µm, 40 µm and 50 µm 
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particles. All samples exhibit narrow size distributions and excellent homogeneity, illustrated 
in Figure 2c-f.
We demonstrate the suitability of the method presented for 3D cell culture application by 
encapsulating living mesenchymal stem cells (MSCs) into microgels. We choose a cell type 
which demonstrates an increased susceptibility to stress and the properties of the 
surrounding microenvironment.23 We prepare a peptide-functionalized (Arg-Gly-Asp, RGD) 
alginate (MVG, Novamatrix) using carbodiimide chemistry.7 The RGD sequence offers 
integrin binding sites which allow the attachment of the encapsulated cells to the alginate 
network, a necessary requirement for cellular growth of adherent cells like MSCs.7,23 After 
dissolution of the RGD-labeled alginate (2 wt%) in cell culture medium (DMEM 
supplemented with 10% FBS and 1% penicillin/streptomycin (Invitrogen), the calcium-
EDTA complex (50 mM) is added and the solution is vortexed to ensure homogenous 
mixing. Prior to emulsification, the cells are routinely cultured, trypsinized and resuspended 
in the alginate-calcium-EDTA solution. We use a cell density of 3.6 × 106 cells/mL. The 
cell-containing alginate-Ca-EDTA mixture is emulsified into monodisperse droplets using a 
flow-focusing device as shown in Figure 3a. We find that this cell density results in 25 % of 
the droplets generated carrying single cells while the majority of drops (70 %) remains 
empty. The number of drops in which more than one cell is encapsulated is small, and is in 
good agreement with the number expected from the Poisson distribution as illustrated in 
Figure 3b.24,25 This number can be set by adjusting the cell density accordingly.24 Gelation 
of the droplets is induced by subsequent addition of acetic acid (0.05 vol%) to the oil phase. 
Under these conditions, we find that a crosslinking time of two minutes is sufficient to 
ensure complete gelation of the droplets. After crosslinking, the gels are washed to remove 
residual acid and EDTA and redispersed in cell culture medium. Using a calcein-AM assay, 
we stain the living cells inside the microgels and find that 83 % of the cells remain viable 
after encapsulation and crosslinking. Longer crosslinking times, i.e. extended exposure of 
the encapsulated cells to the acidic environment result in increased cell mortality. After 30 
minutes of crosslinking no living cells remain as illustrated in Figure 3c. Higher 
concentrations of acetic acid during the crosslinking period show the same effect (data not 
shown). Lower concentrations of acetic acid are not sufficient to induce complete gelation of 
the particles as shown in Figure S3. We incubate and culture the encapsulated MSCs under a 
CO2 atmosphere at 37 °C to ensure optimal culturing conditions. The cells are clearly 
embedded in the microcompartments formed by the alginate hydrogels; the microgels 
remain intact and we observe no leakage of cells after encapsulation or while being cultured. 
We find that the cells keep their spherical shape when being cultured inside the microgel 
particle as shown in Figure 4a; this has also been reported for bulk three dimensional culture 
systems.23,26 Huebsch and colleagues were able to show that cells encapsulated in RGD-
functionalized alginate interact with the surrounding matrix via αV integrins while 
maintaining their spherical shape.23 The cells are therefore able to adhere to the hydrogel 
matrix and maintain in a healthy and viable state inside the hydrogel matrix. After 
incubating the cells for several days, we see growth and proliferation of the cells inside the 
microgel particles. We observe cell division reflected by an increase in the number of cells 
present in the microgel matrix as is shown, for example, for cell-containing microgels that 
had been encapsulated for 15 days in Figure 4b. We find a high cell viability of 70% after 
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two weeks of culture and observe only a slight decrease in the cell viability with proceeding 
incubation time as illustrated in Figure 4c. We believe that the cell viability can be further 
increased by adjustment of the hydrogel’s mechanical properties and degradation behavior. 
The degradation behavior of alginate can be enhanced by γ-irradiation or controlled 
oxidation which has been shown to significantly improve the viability of encapsulated 
cells.29,30 Alternatively, composites of alginate and a degradable polymer like gelatin can be 
used to enhance the cell viability during long-term culture.31,32 Nevertheless, the cellular 
growth and proliferation observed confirm efficient solid support as well as sufficient 
delivery of nutrients and oxygen to the encapsulated cells as shown in Figure 4d. This 
method can thus not only be used for the encapsulation of living cells but also for culturing 
of cells in highly controlled microgel matrices and may help to gain insights in cellular 
behavior in 3-dimensional environments. Additionally, the described incorporation of 
degradable moieties can be used to investigate cell-matrix interactions in further detail and 
study the self-organization of cells with proceeding degradation of the surrounding matrix.
In conclusion, we present a new method for the microfluidic fabrication of monodisperse 
alginate microgels with superior structural homogeneity. The use of a water-soluble calcium 
complex as crosslinking precursor allows us to homogenously distribute calcium ions within 
the generated alginate droplets. Subsequently, the dissociation of the complex is triggered by 
pH reduction resulting in the gelation of the droplets. We present the suitable of this 
approach for the encapsulation of living mesenchymal stem cells which are cultured inside 
the generated microenvironments for 15 days. During this period, we observe a stable 
encapsulation, cell growth and proliferation. We believe that this method will enable a 
precise tuning of the mechanical properties of the microgel through control of the amount of 
crosslinker and the nature of the alginate chains. This will help generate reliable three-
dimensional cell culture systems for the investigation the relation between matrix 
characteristics and cell behavior in three dimensions; this is of major importance for stem 
cell research, wound healing and the treatment of diseases. The small size of the microgels is 
attractive for applications such as injectable cell-delivery systems in regenerative medicine 
allowing the delivery of cells to repair damaged tissue in a minimally invasive fashion. 
Finally, these tailored microenvironments serve as building blocks that can be assembled 
into more complex structural arrangements mimicking the complexity of real biological 
systems like tissues or organs. Thus, more realistic model systems are available which will 
result in more physiologically relevant data obtained from in vitro cultures, for example, in 
drug testing and development or tissue engineering applications.
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Figure 1. 
Microfluidic generation of homogeneously crosslinked alginate microparticles by on 
demand release of calcium ions from a water-soluble calcium-EDTA complex. a) Reaction 
scheme for the formation and dissociation of the calcium-EDTA complex. Under neutral 
conditions (pH 7.0) the calcium ions are chelated by the EDTA molecules. In an acidic 
environment (pH 5.0), the reverse reaction takes place resulting in a release of calcium ions 
which can then form an ionic network with the alginate chains. b,c) Schematic illustration 
(b) and microscopic image (c) of the microfluidic flow-focusing device used for the 
fabrication of alginate microbeads (scale bar: 50 µm). d) Schematic illustration of the 
crosslinking process. Upon addition of acid to the continuous phase, the calcium-EDTA 
complex dissolves, calcium ions are released and crosslinking of alginate is induced.
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Figure 2. 
a,b) Bright-field and fluorescent images of alginate microbeads after transfer into aqueous 
medium. The images reflect the high monodispersity of the spherical particles. The high-
magnification fluorescent image reveals the homogeneous structure of the alginate 
microbeads. c-f) Representative bright-field images and corresponding size distribution 
histograms of homogeneous alginate microbeads with 10, 25, 40 and 50 µm in diameter. The 
gels are prepared using three different microfluidic devices (10 µm, 25 µm and 50 µm 
channels). The flow rate of the inner phase (alginate-calcium-EDTA) solution is 50 µL/h. 
Utech et al. Page 10
Adv Healthc Mater. Author manuscript; available in PMC 2016 August 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The flow rate of the continuous oil phase is varied between 100 µL/h and 500 µL/h to adjust 
the size of the droplets for a given microfluidic device. By separating the gelation from the 
drop formation process and the use of merely water-soluble materials a precise control of the 
drop formation and hence, particle size and size distribution is achieved. All scale bars are 
50 µm.
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Figure 3. 
Microfluidic fabrication of cell-laden microbeads. a) Cells are encapsulated using a 50 µm 
flow-focusing device (scale bar: 100 µm). Single-cell containing droplets are indicated by 
white arrows. b) The encapsulation process follows the Poisson distribution and results in 
approximately 25 % of single-cell containing droplets with negligible multi-cell 
encapsulation. c) The cell viability is highly dependent on the gelation time of the 
microbeads. By limiting the gelation time to 2 minutes, a cell viability of 83 % after 
encapsulation is achieved (*=viability of cells before encapsulation).
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Figure 4. 
a) Microscopic image of alginate microgels directly after cell encapsulation and transfer into 
aqueous medium. In good agreement with the Poison statistics, the majority of gels is empty 
and several single-cell containing gels are visible. b) After 15 days in culture, gels 
containing multiple cells are present. We observe no leakage of cells or disintegration of the 
microgel matrix during this periode. c) Cell viability is determined via calcein staining. 
After 15 days in culture we determine a viability of 70 %. d) Representative images of cell-
containing alginate gels directly after encapsulation and after being cultured for 3, 6, 12 and 
15 days, reprehensively. The cells grow and proliferate inside the generated 
microenvironments while maintaining their spherical morphology. The encapsulated cells 
are stained using a calcein assay and analyzed via confocal laser scanning microscope to 
determine the cell viability (inlets). All scale bars are 25 µm.
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